CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model

Malaria is a major global health problem, with severe mortality in children living is Sub-Saharan Africa, and there is currently no licensed effective vaccine. However, vaccine-induced protection from Plasmodium infection, the causative agent of malaria, was established for humans in small clinical...

Full description

Bibliographic Details
Main Authors: John eHarty, Natalija eVan Braeckel-Budimir
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00272/full
id doaj-dc92801f373c436496bb0beb54a08446
record_format Article
spelling doaj-dc92801f373c436496bb0beb54a084462020-11-24T22:55:21ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2014-06-01510.3389/fmicb.2014.0027292525CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse modelJohn eHarty0Natalija eVan Braeckel-Budimir1University of IowaUniversity of IowaMalaria is a major global health problem, with severe mortality in children living is Sub-Saharan Africa, and there is currently no licensed effective vaccine. However, vaccine-induced protection from Plasmodium infection, the causative agent of malaria, was established for humans in small clinical trials and for rodents in the 1960’s. Soon after, a critical role for memory CD8 T cells in vaccine induced protection against Plasmodium liver-stage infection was established in rodent models and is assumed to apply to humans. However, these seminal early studies have led to only modest advances over the ensuing years in our understanding the basic features of memory CD8 T cells required for protection against liver-stage Plasmodium infection, an issue which has likely impeded the development of effective vaccines for humans. Given the ethical and practical limitations in gaining mechanistic insight from human vaccine and challenge studies, animal models still have an important role in dissecting the basic parameters underlying memory CD8 T cell immunity to Plasmodium. Here, we will highlight recent data from our own work in the mouse model of Plasmodium infection that identify quantitative and qualitative features of protective memory CD8 T cell responses. Finally, these lessons will be discussed in the context of recent findings from clinical trials of vaccine–induced protection in controlled human challenge models.http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00272/fullHumansMemoryMicePlasmodiumprotectionCD8 T cells
collection DOAJ
language English
format Article
sources DOAJ
author John eHarty
Natalija eVan Braeckel-Budimir
spellingShingle John eHarty
Natalija eVan Braeckel-Budimir
CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
Frontiers in Microbiology
Humans
Memory
Mice
Plasmodium
protection
CD8 T cells
author_facet John eHarty
Natalija eVan Braeckel-Budimir
author_sort John eHarty
title CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
title_short CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
title_full CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
title_fullStr CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
title_full_unstemmed CD8 T cell-mediated protection against liver-stage malaria: Lessons from a mouse model
title_sort cd8 t cell-mediated protection against liver-stage malaria: lessons from a mouse model
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2014-06-01
description Malaria is a major global health problem, with severe mortality in children living is Sub-Saharan Africa, and there is currently no licensed effective vaccine. However, vaccine-induced protection from Plasmodium infection, the causative agent of malaria, was established for humans in small clinical trials and for rodents in the 1960’s. Soon after, a critical role for memory CD8 T cells in vaccine induced protection against Plasmodium liver-stage infection was established in rodent models and is assumed to apply to humans. However, these seminal early studies have led to only modest advances over the ensuing years in our understanding the basic features of memory CD8 T cells required for protection against liver-stage Plasmodium infection, an issue which has likely impeded the development of effective vaccines for humans. Given the ethical and practical limitations in gaining mechanistic insight from human vaccine and challenge studies, animal models still have an important role in dissecting the basic parameters underlying memory CD8 T cell immunity to Plasmodium. Here, we will highlight recent data from our own work in the mouse model of Plasmodium infection that identify quantitative and qualitative features of protective memory CD8 T cell responses. Finally, these lessons will be discussed in the context of recent findings from clinical trials of vaccine–induced protection in controlled human challenge models.
topic Humans
Memory
Mice
Plasmodium
protection
CD8 T cells
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2014.00272/full
work_keys_str_mv AT johneharty cd8tcellmediatedprotectionagainstliverstagemalarialessonsfromamousemodel
AT natalijaevanbraeckelbudimir cd8tcellmediatedprotectionagainstliverstagemalarialessonsfromamousemodel
_version_ 1725656732297854976